Dr. Yi-Dan Denise Chen, Ph.D.
Executive Partner in North America, GTJA Investment Group
Dr. Chen has worked as a research scientist at Harvard Medical School, Technical Lead, CTO, and a senior consultant for the APAC headquarter of Agilent Technologies (Seahorse Bioscience), Director of Strategic Development of Beijing Promed, Cofounder of I&I Ventures (a global med-tech VC), etc. She has led M&A, IPO, fund-raising, and out-licensing of several companies as a member of the core management team or as a senior consultant. She has extensive professional background and connections in healthcare industries, with expertise in VC investment and US-China strategic business development. Investment cases: Seahorse Bioscience, Beijing Promed, BRIM Biotech etc.
She has Ph.D. in Pharmacology, School of Medicine, UC San Diego.